ACR launches breast MR accreditation program
The ACR has added breast MRI to its repertoire of accreditation programs.
The ACR has added breast MRI to its repertoire of accreditation programs. The Breast Magnetic Resonance Imaging Accreditation Program enables facilities to improve and maintain the quality of their breast MRI services through a peer-review assessment of their processes and equipment and the quality of their images. For facilities that do only breast imaging, the accreditation program fulfills the requirements of the Medicare Improvements for Patients and Providers Act of 2008.
The program will evaluate the qualifications of its personnel, performance of its equipment, effectiveness of its quality control measures, and image quality, said Dr. Constance Lehman, chair of the ACR’s committee on breast MRI accreditation.
Facilities must submit clinical images and corresponding data for each magnet performing breast MRI exams at their site. Each site must have the capacity to perform mammographic correlation, directed breast ultrasound, and MR-guided intervention, or create a referral arrangement with a cooperating facility that could provide these services.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
